Related Experiment Video
Updated: Nov 4, 2025

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
Published on: June 2, 2022
Dexmedetomidine & perioperative analgesia in children
R Eizaga Rebollar1, M V García Palacios2, M Del Carmen Fernández Riobó1
1Servicio de Anestesiología y Reanimación, Hospital Universitario Puerta de Mar, Cádiz, España.
Insights
Dexmedetomidine (DEX) offers safe and effective perioperative analgesia for pediatric patients, mimicking sleep with minimal cardiorespiratory impact. This review evaluates its role, effectiveness, and safety in pediatric anesthesia.
Area of Science:
- Anesthesiology
- Pediatric Pharmacology
- Pain Management
Background:
- Dexmedetomidine (DEX) is an anesthetic agent known for its sleep-like sedation and minimal cardiorespiratory depression.
- Pediatric patients present unique challenges in anesthesia management.
- DEX is a potential option for managing pain and anxiety in children undergoing surgery.
Purpose of the Study:
- To conduct a mini-review evaluating the role of Dexmedetomidine (DEX) as a perioperative analgesic in pediatric anesthesia.
- To assess the pharmacology, effectiveness, safety, and recent clinical evidence of DEX in children.
- To provide a cost estimate for perioperative analgesia using DEX in pediatric patients.
Main Methods:
- Literature search conducted on Google, PubMed, Embase, and Cochrane Library.
- Inclusion criteria: articles published between 2010 and 2021.
- Review focused on DEX pharmacology, efficacy, safety, and clinical use in pediatric anesthesia, including cost analysis.
Main Results:
- Dexmedetomidine (DEX) demonstrates significant potential as a perioperative analgesic in pediatric anesthesia.
- Evidence suggests favorable effectiveness and safety profiles, with minimal cardiorespiratory compromise.
- The review synthesizes recent findings on DEX's clinical application and economic considerations.
Conclusions:
- Dexmedetomidine (DEX) is a valuable agent for perioperative analgesia in pediatric patients.
- Its sleep-mimicking properties and low cardiorespiratory impact make it suitable for this population.
- Further research supports DEX's role in enhancing pediatric anesthesia care.
Abstract:
Dexmedetomidine (DEX) is an anaesthetic agent that mimics natural deep sleep and produces minimal cardiorespiratory depression. As such, it is a very valuable option in the management of such a challenging population as paediatric patients. The main objective of this mini review was to evaluate the role of DEX as a perioperative analgesic in children receiving anaesthesia. We searched Google, Pubmed, Embase and the Cochrane Library for articles published between 2010 and 2021, and reviewed various of aspects of DEX, such as pharmacology, effectiveness, safety, and the most recent evidence on its clinical use as an analgesic in paediatric anaesthesia. We also include a cost estimate of perioperative analgesia with DEX.
Related Concept Videos
Parenteral Anesthetics: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Inhalational Anesthetics: Overview
Stages of General Anesthesia

